{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT03455972: Phase 1/Phase 2 Interventional Unknown status Safety and Efficacy
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04262479: Phase 2 Interventional Completed Latent Autoimmune Diabetes in Adults
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
USAN:BIROPEPIMUT-S [USAN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03704766: Not Applicable Interventional Recruiting Joint Infection
(2016)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT00791570: Phase 1 Interventional Completed Neovascular Maculopathy
(2008)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02672163: Not Applicable Interventional Completed Heart Failure
(2016)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01978912: Phase 1/Phase 2 Interventional Completed Lumbar Disc Herniation
(2013)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03249207: Phase 3 Interventional Active, not recruiting Subarachnoid Hemorrhage
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01487915: Phase 2 Interventional Unknown status Advanced Urothelial Carcinoma
(2010)
Source URL:
Class:
PROTEIN
